You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Avastin

Showing 1 - 25 of 1,460
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Male Subjects Trial in Changchun (HLX04, US-Avastin®, EU-Avastin®)

Completed
  • Healthy Male Subjects
  • Changchun, Jilin, China
    The First Hospital of Jilin University
May 6, 2022

Glioblastoma Multiforme Trial in Philadelphia (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Philadelphia, Pennsylvania
    (unnamed)
Aug 8, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Miami, Florida
    University of Miami
Sep 30, 2022

Colorectal Cancer Trial (Avastin/FOLFIRI, Curcumin)

Completed
  • Colorectal Cancer
  • (no location specified)
Mar 28, 2022

Breast Cancer Trial in Oslo, Trondheim (Aromatase Inhibitor, Bevacizumab, Epirubicine)

Completed
  • Breast Cancer
  • Aromatase Inhibitor
  • +6 more
  • Oslo, Norway
  • +2 more
Jan 5, 2023

Glioblastoma Multiforme, Brain Tumor Trial in New York (Bevacizumab)

Active, not recruiting
  • Glioblastoma Multiforme
  • Brain Tumor
  • New York, New York
    Lenox Hill Brain Tumor Center
Jun 20, 2022

Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • PBT and atezolizumab/bevacizumab
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 15, 2022

Healthy Trial in Zuidlaren (MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R))

Completed
  • Healthy
  • Zuidlaren, Netherlands
    PRA Health Sciences - Early Development Services
Mar 9, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab

Completed
  • Diabetic Macular Edema
  • Bevacizumab Injection [Avastin] (IVB-I)
  • +2 more
  • (no location specified)
May 24, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))

Completed
  • Rectal Cancer
  • +4 more
  • Bevacizumab injection
  • Bevacizumab injection（Avastin）
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Jul 25, 2022

Avastin in Metastatic Colorectal Cancer (KORALLE)

Completed
  • Colorectal Cancer
  • (no location specified)
Nov 30, 2021

Efficacy Trial in Suzhou (TAB008, Bevacizumab)

Completed
  • Efficacy
  • Suzhou, Jiangsu, China
    TOT
Jun 16, 2022

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

Suspended
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +8 more
Jul 19, 2022

Vestibular Schwannoma Trial in New York (Bevacizumab (Avastin))

Suspended
  • Vestibular Schwannoma
  • Bevacizumab (Avastin)
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Eindhoven, Netherlands
  • +1 more
Aug 15, 2023

EGFR Positive NSCLC Trial in Goyang-Si (Erlotinib plus Bevacizumab, Erlotinib)

Active, not recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

NSCLC(NSCLC) Trial in Nanjing (BP102, paclitaxel, carboplatin, Avastin®, paclitaxel, carboplatin)

Completed
  • Non-small Cell Lung Cancer(NSCLC)
  • BP102, paclitaxel, carboplatin
  • Avastin®, paclitaxel, carboplatin
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Dec 23, 2021